Abstract
The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) mediates endocytosis of a number of structurally unrelated ligands, including complexes of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) or urokinase plasminogen activator (u-PA), free t-PA, single-chain urokinase (pro-u-PA), alpha 2-macroglobulin-protease complexes, and lipoprotein lipase. So far, all ligands have in common the fact that they bind to the receptor in a Ca(2+)-dependent way and the fact that binding to the receptor can be inhibited by a 39-40-kDa protein, termed the receptor-associated protein. To obtain inhibitory antibodies for the analysis of the structure and function of the receptor we applied the combinatorial immunoglobulin repertoire cloning technique in order to specifically select monoclonal Fab fragments directed against Ca(2+)-dependent epitopes. In this report we describe the isolation of a Fab fragment (Fab A8) showing a high relative affinity for the receptor (0.5 nM). The binding of this Fab fragment to purified LRP is inhibited in the presence of 5 mM EDTA, receptor-associated protein, and lipoprotein lipase (IC50 values of 1.4 and 31 nM, respectively). By immun...Continue Reading
References
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K OrthJ Herz
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G BuA L Schwartz
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·U BeisiegelG Bengtsson-Olivecrona
Dec 10, 1990·FEBS Letters·T KristensenL Sottrup-Jensen
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D R BurtonR A Lerner
Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasS J Benkovic
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A S KangR A Lerner
Dec 1, 1990·Cell Regulation·P H JensenP A Andreasen
Feb 10, 1988·Journal of Immunological Methods·S RathM W Steward
Jul 1, 1970·The Journal of Experimental Medicine·B Andersson
Jun 3, 1994·Science·T E WillnowJ Herz
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·I WarshawskyA L Schwartz
Jun 29, 1994·Biochimica Et Biophysica Acta·S K Moestrup
Jan 1, 1994·Annual Review of Biochemistry·M Krieger, J Herz
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·F HoferD Blaas
Aug 1, 1993·The Journal of Clinical Investigation·I WarshawskyA L Schwartz
Citations
Jul 22, 1998·Progress in Neurobiology·H V WhealJ Kirsch
Jan 11, 2001·Trends in Cardiovascular Medicine·J G NeelsP J Lenting
Mar 10, 2001·The Biochemical Journal·T ChitlaruA Shafferman
May 28, 2010·The Journal of Biological Chemistry·Henry R MaunSarah G Hymowitz
Aug 17, 1999·Annual Review of Nutrition·M M HussainA Bakillah
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·R A OrlandoM G Farquhar
Jan 30, 2007·Protein Expression and Purification·Daniel Iván BarreraLuis Fernando Arbeláez
Sep 3, 2003·European Journal of Haematology·Ivo R HornSøren K Moestrup
Jan 7, 1997·Circulation·E A BiessenJ Kuiper
Oct 28, 1996·FEBS Letters·D M PfistermuellerR A Hodits
Dec 14, 2004·Blood·Guangyao YuBruce S Sachais
Jul 26, 2003·Blood·Khalil BdeirDouglas B Cines
Sep 27, 2003·Blood·Taher NassarAbd Al-Roof Higazi
Aug 14, 1999·The Journal of Biological Chemistry·P J LentingA J van Zonneveld
Oct 26, 1999·The Journal of Biological Chemistry·J G NeelsA J van Zonneveld
Oct 6, 1995·The Journal of Biological Chemistry·M S NielsenJ Gliemann
Aug 17, 2001·The Journal of Biological Chemistry·I MikhailenkoD K Strickland
May 23, 1997·The Journal of Biological Chemistry·I R HornA J van Zonneveld